NY Fed’s Bogus Estimate of Return on College and Brookings Misses the Student Loan Crisis
Yves at Naked Capitalism writes “NY Fed’s Bogus Estimate of Return on College and the Neglect of the Intellectual Commons” Yesterday, the New York Fed...
Category : Home
Truly Inane Bloomberg Analysis On Gold
Bad economic analysis abounds. Some of it is so bad you wonder if the authors understand how any markets work, not just the topic of...
Diving Into the GDP Report of -2.9% Growth
The first quarter GDP initial projection was 0.1%. The second estimate came in at -1.0%. Today the third estimate came in at -2.9%.Gosh, first quarter...
Watch out! The Stock Market is Slow
How slow has the stock market gotten? Answer: All time extremes in slow. Volatility, daily ranges, and even volume have all fallen to levels not...
Q1 GDP Revised Down to -2.9% Annual Rate
From the BEA: Gross Domestic Product: First Quarter 2014 (Third Estimate)Real gross domestic product -- the output of goods and services produced by labor and...
Asia’s Singapore Aims To Become A Major Global Gold Trading Hub – Launching New Gold Trading Contracts
Oil and gold have been in a long term relationship with each other, and as like most relationships it has been both blissful and at...
Where The Economist “Big Mac” Index Finds Currency Value
My former employer, The Economist, once the ever tolerant editor of my flabby, disjointed, and juvenile prose (Thanks Peter and Marjorie), has released its “Big...
Argentina’s holdout debt dilemma
We've received a number of questions regarding the implications of the recent US court ruling on Argentina. In spite of the complexities involved, the situation...
House Prices: Real Prices and Price-to-Rent Ratio decline slightly in April
On a seasonally adjusted monthly basis, the Case-Shiller Composite 20 index was up 0.2% in April - and the Composite 10 was close to unchanged...
Vertex Pharmaceuticals Incorporated (VRTX): Hal Mintz, David Shaw, and Phill Gross Are Big Winners
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is up more than 42% after reporting successful results of its cystic fibrosis treatment. Tech Insider yesterday published an article about a...